- Title
- Durable Response to Larotrectinib in a Child With Histologic Diagnosis of Recurrent Disseminated Ependymoma Discovered to Harbor an NTRK2 Fusion: The Impact of Integrated Genomic Profiling
- Creators
- Ross Mangum - Baylor College of MedicineJacquelyn Reuther - Baylor College of MedicineKelsey C Bertrand - Baylor College of MedicineRaghu Chandramohan - Baylor College of MedicineMarcia K Kukreja - Texas Children's HospitalArnold C Paulino - The University of Texas MD Anderson Cancer CenterDonna Muzny - Baylor College of MedicineJianhong Hu - Baylor College of MedicineRichard A Gibbs - Baylor College of MedicineDaniel J Curry - Baylor College of MedicineFatema Malbari - Texas Children's HospitalMurali M Chintagumpala - Baylor College of MedicineAdekunle M Adesina - Baylor College of MedicineKevin E Fisher - Texas Children's HospitalStephen C Mack - Baylor College of MedicineSharon E Plon - Baylor College of MedicineAngshumoy Roy - Baylor College of MedicineD Williams Parsons - Baylor College of MedicineFrank Y Lin - Baylor College of Medicine
- Publication Details
- JCO precision oncology, Vol.5(5), pp.1221-1227
- Identifiers
- 991006262516002656
- Academic Unit
- Pediatrics
- Language
- English
- Resource Type
- Journal article
Journal article
Durable Response to Larotrectinib in a Child With Histologic Diagnosis of Recurrent Disseminated Ependymoma Discovered to Harbor an NTRK2 Fusion: The Impact of Integrated Genomic Profiling
JCO precision oncology, Vol.5(5), pp.1221-1227
2021
PMID: 34651095
Metrics
1 Record Views